The Effects of miR‐20a on p21: Two Mechanisms Blocking Growth Arrest in TGF‐β‐Responsive Colon Carcinoma
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Loss of response to TGF‐β is a central event in the genesis of colorectal cancer (CRC), a disease that, in the majority cases, is refractory to growth inhibition induced by this cytokine. However, inactivating mutations at receptors and transducers from the TGF‐β cascade occur only in approximately half of CRCs, suggesting the involvement of additional mechanisms altering the response to the cytokine. We have recently described the amplification of the 13q31 locus, where the miR‐17–92 cluster maps, associated with overexpression of its members. In this study, we address the potential role of miR‐20a, from the miR‐17–92 cluster, in the suppression of TGF‐β cytostatic response in CRC. Using the poorly tumorigenic and TGF‐β‐sensitive FET cell line that expresses low miR‐20a levels, we first confirmed that miR‐20a downmodulated CDKN1A expression, both at mRNA and protein level, through direct binding to its 3′‐UTR. We demonstrated that miR‐20a significantly diminished cell response to TGF‐β by preventing its delay of G1/S transition and promoting progression into cell cycle. Moreover, besides modulating CDKN1A, miR‐20a blocked TGF‐β‐induced transactivation of its promoter without affecting the post‐receptor activation of Smad3/4 effectors directly. Finally, miR‐20a abrogated the TGF‐β‐mediated c‐Myc repression, a direct inhibitor of the CDKN1A promoter activation, most likely by reducing the expression of specific MYC‐regulating genes from the Smad/E2F‐based core repressor complex. Our experiments i ndicate that miR‐20a interferes with the colonic epithelium homeostasis by disrupting the regulation of Myc/p21 by TGF‐β, which is essential for its malignant transformation. J. Cell. Physiol. 230: 3105–3114, 2015. © 2015 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · cited 1×
“Mutations at TGFBR2, ACVR2, and their SMAD effectors occur at a significant frequency (Lao and Grady, 2011; Network, 2012; Lawrence et al., 2014), and TGFBR2, together with KRAS mutations is associated with late adenoma malignant transformation (Grady et al., 1998).”
Backgroundpl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950 · cited 1×
“…of growth promoting factors, such as the MYC proto-oncogene, (Mulder et al., 1988) and the consequent activation of cyclin-dependent kinase (CDK) inhibitors, such as CDKN1A (p21/WAF1) and CDKN2B (p15) (Hannon and Beach, 1994; Datto et al., 1995, Reynisdottir et al., 1995; Claassen and Hann, 2000).”
BackgroundMolecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma
Mestdagh, P., Boström, A.-K., Impens, F., Fredlund, E., Van Peer, G., De Antonellis, P., von Stedingk, K., Ghesquière, B., Schulte, S., Dews, M., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.038 · Cited by 314
Cited by
Pu, M., Chen, J., Tao, Z., Miao, L., Qi, X., Wang, Y., & Ren, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2940-7 · Cited by 500
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M., Araujo, A., Araiz, M., Fernandez-Mercado, M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050627 · Cited by 239
“These miRNAs also target senescence (p21/CDKN1A) [290,291], metastasis (DLC1 and TIMP2) [292–294], cell cycle regulation (E2F family members, RB1 and p21/CDKN1A), and angiogenesis (THBS1 and CTGF) [295–297].”
BackgroundMicroRNAs in the etiology of colorectal cancer: Pathways and clinical implications
Strubberg, A. M., & Madison, B. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027441 · Cited by 147
MicroRNA controls of cellular senescence
Suh, N. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.10.209 · Cited by 78
“In a colon-carcinoma cell line, miR-20a downmodulates p21 expression and abrogates TGF--induced G1/S arrest (63).”
Background
Metadata
- Authors
- Sokolova, V., Fiorino, A., Zoni, E., Crippa, E., Reid, J. F., Gariboldi, M., & Pierotti, M. A.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2015-08-24
- Volume
- 230
- Issue
- 12
- Pages
- 3105-3114
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2140766433
- Cited by
- 57
- References
- 5
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.